PARTNER NEWS:Fri, May 10, 11:34 AM, Zacks
bluebird (BLUE) Tops on Q1 Sales, Zynteglo Progresses Well
bluebird (BLUE) beats sales estimates in the first quarter on increased Zynteglo product revenues. The company is on track with the ongoing launch of its gene therapies.
Thu, Apr 25, 8:02 AM, Zacks
Zoetis (ZTS) to Report Q1 Earnings: What's in the Cards?
Zoetis (ZTS) higher companion animal product sales are expected to have driven revenues in the first quarter of 2024 in both the United States and International segments.